Asenapine and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is reported as a side effect among people who take Asenapine (asenapine), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Depakote, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Drowsiness when taking Asenapine. It is created by eHealthMe based on reports of 696 people who have side effects when taking Asenapine from the FDA, and is updated regularly.

What is Asenapine?

Asenapine has active ingredients of asenapine. eHealthMe is studying from 706 Asenapine users. Check the latest studies of Asenapine.

What is Drowsiness?

Drowsiness is found to be associated with 2,865 drugs and 4,797 conditions by eHealthMe. Check the latest studies of Drowsiness.

On Jul, 10, 2026

696 people reported to have side effects when taking Asenapine.
Among them, 40 people (5.75%) have Drowsiness.

Among these 40 people:

How long have people been on Asenapine when they have Drowsiness? *

What is the gender of people who have Drowsiness when taking Asenapine? *

female: 25.71 %
male: 74.29 %

What is the age of people who have Drowsiness when taking Asenapine? *

What are other drugs people take besides Asenapine? *

Depakote: 20 people, 50.00%
Lamotrigine: 17 people, 42.50%
Haldol: 16 people, 40.00%
Aspirin: 14 people, 35.00%
Donepezil: 12 people, 30.00%
Olanzapine: 3 people, 7.50%
Clozapine: 3 people, 7.50%
Paliperidone: 3 people, 7.50%
Donepezil Hydrochloride: 2 people, 5.00%
Escitalopram: 2 people, 5.00%

What are other side effects people have besides Drowsiness? *

Hypotension (abnormally low blood pressure): 23 people, 57.50%
Sedation: 21 people, 52.50%
Depression: 20 people, 50.00%
Oedema (fluid collection in tissue): 19 people, 47.50%
Cellulitis (infection under the skin): 18 people, 45.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 17 people, 42.50%
Drug Resistance (reduction in effectiveness of a drug): 17 people, 42.50%
Conjunctivitis (pink eye): 17 people, 42.50%
Hearing Loss: 17 people, 42.50%
Disease Recurrence: 17 people, 42.50%

What are the existing conditions these people have? *

Bipolar Disorder (mood disorder): 7 people, 17.50%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 4 people, 10.00%
Irritability: 3 people, 7.50%
Hallucinations (sensations that appear real but are created by your mind): 3 people, 7.50%
Substance-Induced Psychotic Disorder: 3 people, 7.50%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 7.50%
Agitation (state of anxiety or nervous excitement): 3 people, 7.50%
Persecutory Delusion: 3 people, 7.50%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 3 people, 7.50%
Hallucination, Auditory (perceiving sounds without auditory stimulus): 3 people, 7.50%

* Approximation only. Some reports may have incomplete information.

Do you take Asenapine and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Asenapine:

Asenapine (706 reports)

Drowsiness treatments and more:

Drowsiness (269,040 reports)

Browse all side effects of Asenapine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drowsiness:

Drowsiness (2,865 drugs)

Browse all the conditions that are associated with Drowsiness:

Drowsiness (4,797 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on asenapine (the active ingredients of Asenapine) and Asenapine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.